Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Acquired by Greylin Investment Management Inc

Greylin Investment Management Inc increased its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 26.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 425,226 shares of the pharmacy operator's stock after purchasing an additional 87,660 shares during the quarter. Walgreens Boots Alliance accounts for 1.9% of Greylin Investment Management Inc's portfolio, making the stock its 8th largest position. Greylin Investment Management Inc's holdings in Walgreens Boots Alliance were worth $11,103,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in WBA. EverSource Wealth Advisors LLC boosted its holdings in Walgreens Boots Alliance by 308.4% in the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator's stock worth $25,000 after purchasing an additional 845 shares during the last quarter. Highlander Capital Management LLC purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter worth $26,000. Venturi Wealth Management LLC boosted its stake in shares of Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator's stock worth $28,000 after acquiring an additional 981 shares during the last quarter. FinTrust Capital Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 2,314.5% during the 3rd quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator's stock worth $30,000 after acquiring an additional 1,273 shares during the last quarter. Finally, Rocky Mountain Advisers LLC purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter worth $30,000. Hedge funds and other institutional investors own 58.59% of the company's stock.

Insider Transactions at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, April 2nd. The shares were purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, CFO Manmohan Mahajan purchased 6,000 shares of the company's stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, with a total value of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nancy M. Schlichting sold 15,209 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $23.05, for a total transaction of $350,567.45. The disclosure for this sale can be found here. Insiders own 17.40% of the company's stock.

Walgreens Boots Alliance Price Performance

NASDAQ WBA traded up $0.02 on Tuesday, reaching $19.18. The company had a trading volume of 11,093,244 shares, compared to its average volume of 14,479,449. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $16.55 billion, a PE ratio of -2.74, a price-to-earnings-growth ratio of 1.18 and a beta of 0.73. The firm's 50 day moving average price is $21.19 and its 200 day moving average price is $22.14. Walgreens Boots Alliance, Inc. has a 12 month low of $18.49 and a 12 month high of $36.58.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. During the same period in the previous year, the firm posted $1.16 EPS. The business's quarterly revenue was up 6.3% on a year-over-year basis. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on WBA shares. Barclays started coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They set an "underweight" rating and a $21.00 price target on the stock. Morgan Stanley dropped their price target on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an "underweight" rating on the stock in a research note on Monday, April 1st. Truist Financial reiterated a "hold" rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Raymond James restated a "market perform" rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Finally, UBS Group decreased their price objective on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 3rd. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $24.36.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.